Blueberries MedicalBBRRF Gross Margin % is 61.29% as of Mar. 2026, which is 91% above its 10-year median of 32.10. The stock has 2 warning signs investors should review. Among 936 Drug Manufacturers companies, Blueberries Medical ranks better than 52.88% on this metric.
The historical rank and industry rank for Blueberries Medical's Gross Margin % or its related term are showing as below:
BBRRF'
s Gross Margin % Range Over the Past 10 Years
Min: -176.26 Med: 32.1 Max: 93.94
Current: 50.5
During the past 13 years, the highestGross Margin % of Blueberries Medical was 93.94%. The lowest was -176.26%. And the median was 32.10%.
BBRRF's Gross Margin % is ranked better than 52.88% of 936
companies
in the Drug Manufacturers industry
Industry Median: 48.5
vs BBRRF: 50.50
Blueberries Medical had a gross margin of 61.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Blueberries Medical was 0.00% per year.
Blueberries Medical (OTCPK:BBRRF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Blueberries Medical had a gross margin of 61.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Blueberries Medical Gross Margin % Related Terms
Blueberries Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Blueberries Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Blueberries Medical (BBRRF) has a Gross Margin % of 61.29% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Blueberries Medical and its competitors. This is 91% above median its historical median of 32.10. According to the industry distribution chart, Blueberries Medical ranks #441 out of 936 companies in the Drug Manufacturers industry, placing it in the top 47.1%.
Is Blueberries Medical's Gross Margin % too high?
Blueberries Medical's current Gross Margin % of 61.29% is 91% above median its 10-year median of 32.10. The Drug Manufacturers industry median Gross Margin % is 48.50. Blueberries Medical's value of 61.29% is 26.4% above this industry median. Based on the distribution chart, Blueberries Medical ranks #441 out of 936 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Blueberries Medical's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #441 out of 936 companies for Gross Margin %. This puts Blueberries Medical in the upper half of its industry. The industry median Gross Margin % is 48.50. Blueberries Medical's value of 61.29% is 26.4% above this benchmark. While the company's 10-year median is 32.10 vs. the industry median of 48.50, Blueberries Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.50, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueberries Medical's current Gross Margin % of 61.29% is 26.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current Gross Margin % is 61.29%, which is 91% above median its own 10-year median of 32.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current Gross Margin % of 61.29%. The current Gross Margin % is 61.29%, which is 91% above median its 10-year median of 32.10 and 26.4% above the Drug Manufacturers industry median of 48.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current Gross Margin % is 61.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 